A case of composite neuroblastoma composed of histologically and biologically distinct clones.
We report a case of a 12-month-old girl with stage 3 neuroblastoma composed of 2 distinct clones in the adrenal primary tumor. One clone showed neuroblastoma, poorly differentiated subtype with a low mitosis-karyorrhexis index (favorable histology), and the other was neuroblastoma, poorly differentiated subtype with a high mitosis-karyorrhexis index (unfavorable histology), according to the International Neuroblastoma Pathology Classification. Fluorescent-labeled in-situ hybridization using the formalin-fixed, paraffin-embedded material showed that the MYCN oncogene was amplified in the latter clone but not in the former clone. Lymph nodes from ipsilateral and contralateral sides contained metastatic neuroblastoma of the latter clone. It is well documented that tumors in the Ganglioneuroblastoma, nodular (composite, Schwannian stroma-rich/stroma-dominant and stroma-poor) category are composite and composed of multiple clones. To our knowledge, however, this is the 1st case report of composite tumor with biologically favorable and unfavorable clones in the Neuroblastoma (Schwannian stroma-poor) category.
Sano
Hideki
H
Department of Pathology and Laboratory Medicine, Childrens Hospital Los Angeles and Keck School of Medicine, University of Southern California, 4650 Sunset Blvd, Los Angeles, CA 90027, USA.
Gonzalez-Gomez
Ignacio
I
Wu
Shi Qi
SQ
Armenian
Saro H
SH
Jubran
Rima F
RF
Shimada
Hiroyuki
H
D000310:Adrenal Gland Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology* / Q000601:surgery; D002999:Clone Cells; D005260:Female; D005293:Ferritins / Q000097:blood; D006719:Homovanillic Acid / Q000652:urine; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D007223:Infant; D007770:L-Lactate Dehydrogenase / Q000097:blood; D000071447:N-Myc Proto-Oncogene Protein; D009367:Neoplasm Staging; D009447:Neuroblastoma / Q000145:classification / Q000000981:diagnostic imaging / Q000473:pathology* / Q000601:surgery; D009687:Nuclear Proteins / Q000378:metabolism; D015513:Oncogene Proteins / Q000378:metabolism; D011859:Radiography; D016896:Treatment Outcome; D014642:Vanilmandelic Acid / Q000652:urine
C459801:MYCN protein, human; D000071447:N-Myc Proto-Oncogene Protein; D009687:Nuclear Proteins; D015513:Oncogene Proteins; D014642:Vanilmandelic Acid; D005293:Ferritins; D007770:L-Lactate Dehydrogenase; D006719:Homovanillic Acid